EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Immunization and Cardiovascular Disease in Latin America. The CorVacc Study: Sub Analysis by Regions

Fernando Wyss, Daniel Piskorz, Ricardo Lopez-Santi, Lucelli Yañez Gutiérrez, Horacio Márquez-Gonzales, Fabio Enrique Parada, Vladimir Ullauri, Ana Munera Echeverri, Juan Esteban Gómez, Osiris Valdez, Máxima Méndez, Claudia Almonte, Carlos Ponte-Negretti, María Alayde Mendoça Rivera, Iván Romero Rivera, Raúl Villar, Jorge Alberto Rivera, Dulman Pineda de Paz, Ana Isabel Barrientos, Edmundo Jordan, Gonzalo Piskorz, Pilar Lopez-Santi

Global Heart · 2026-11-12 · 21 (1) · 81

DOI: 10.5334/gh.1600 ↗
AbstractBibliografische Angaben

Abstract

Introduction: In Latin America, the mortality rate from influenza and pneumococcal disease has increased in recent years. Several challenges limit the implementation of vaccination strategies. These factors contribute to lower-than-expected immunization rates in Latin America. Objective: The objective of this sub-analysis of the Inter-American Registry of Influenza and Pneumococcal Vaccination (CorVacc) is to determine vaccination rates and analyze the factors that influence the North – Central America and Carribean Spanish Speaking (NCC); Andean region (AR) and South Cone (SCR). Methods: A cross-sectional survey of the general population was conducted in 19 Latin American countries. Adults aged 18 and older completed a 34-question online survey. Data were grouped into seven categories: demographic, socioeconomic, and non-demographic. Multivariate logistic regression comparisons were performed between regions to assess the association between vaccination rates and their explanatory variables. Results: Influenza, Pneumococcus and ≥3 doses of COVID-19 vaccination was received by 4,126 (45.18%) CAC, 3,576 (50, 13%) AR and 3,024 (62, 99%) SC; 5,904 (65, 09%) CAC, 5,162 (68, 9%) AR and 3,486 (72, 61%) SC; and 6,266 (68, 61%) CAC, 6,001 (80, 09%) AR and 2,892 (79, 99%), respectively. No association was detected between the regions and the likelihood of receiving the influenza vaccine: AR OR 0.94 (95% CI 0.84–1, 06; p = 0.33), CAC OR 0.81 (CI 0.80–1, 00; p = 0.053). On the contrary, a positive association was detected with Streptococcus pneumoniae vaccination: AR OR 1.12 (CI 1, 01–1, 24; p = 0.032), CAC OR 1.33 (CI 1, 20–1, 47; p < 0.001). A negative association was observed in CAC with COVID-19 ≥ 3 doses vaccination: OR 0.56 (CI 0, 65; p = 0.032; p < 0.001). Social, economic and confidence barriers were identified, but cardiovascular risk factors and comorbidities were not significantly associated with lower vaccination rates. Conclusions: Social, economic, and cultural, but not cardiovascular risk factor or disease variables in Latin American region could explain the lower-than-expected rates of vaccination and the differences observed between regions in vaccination frequencies.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →